AONC: aoncology.com Kompaniya qiymatining sof foydaga nisbati

American Oncology Network, Inc. - AONC emitenti grafik logotipi

American Oncology Network (AONC) xususiy amaliyotlarni sotib olish orqali dori-darmon xarajatlarini optimallashtirib, mintaqaviy saraton markazlari segmentini faol ravishda egallamoqda. Ushbu bozor qiymati grafigi -1.00 qiymatini aks ettiradi. Biznes foydani barqarorlashtirish uchun dorixonalar va diagnostikani birlashtirgan integratsiyalashgan yondashuvga tayanadi. Biroq, kengayish iqtidorlar uchun kurash va sog'liqni saqlash gigantlarining bosimi tufayli murakkablashmoqda.

Narx-foyda koeffitsiyenti: AON (AONC) 21.02.2024 - 04.08.2024 uchun

American Oncology Network Inc (AONC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning jamlanma tahlili:AONC, American Oncology Network Inc
American Oncology Network, Inc. yetakchi tovari

Noklinik jarayonlarni autsorsing orqali optimallashtirish American Oncology Network (AONC) kompaniyasining operatsion samaradorligini oshiradi. P/E koeffitsiyenti foydaning bir birligi uchun xarajatni o'lchab, investor aktiv uchun qanchalik ortiqcha to'layotganini aniqlaydi. American Oncology Network (AONC) kompaniyasining P/E koeffitsiyenti dinamikasini tahlil qilish orqali uzoq muddatli tendentsiyaning barqarorligini aniqlash mumkin. Ushbu koeffitsiyentning pasayishi aktivning qadriyatidan past baholanganini yoki xatarlarning ortayotganini anglatadi, barqaror raqam esa bozor kapitalizatsiyasining mustahkamligini va biznes modelining ishonchliligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori AURA|Narx-foyda koeffitsiyenti Candel Therapeutics, Inc. CADL|P/E multiplikatori ARAY (Accuray, Inc.)|SELLAS Life Sciences - Narxning foydaga nisbati|ACTU: Narx-foyda koeffitsiyenti|Citius Oncology, Inc. - Bozor narxining sof foydaga nisbati|HURA (TuHURA Biosciences) - Narx-foyda koeffitsiyenti|TARA: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti FATE|WHWK: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TCRX (TScan Therapeutics Inc)|Biznesning o‘zini qoplash muddati Champions Oncology Inc|P/E multiplikatori XBIT (XBiotech Inc.)|Kompaniya qiymatining sof foydaga nisbati CVM|OS Therapies Inc. - P/E multiplikatori|RADX - P/E multiplikatori|ARTV: P/E multiplikatori|ANL: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti VERU|TPST: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati xiliotx.com (XLO)|Renovaro - Narx-foyda multiplikatori|Narxning foydaga nisbati Mural Oncology MURA|KAPA - Narx-foyda koeffitsiyenti|OKUR - Narxning foydaga nisbati|GDTC - P/E multiplikatori|Curis, Inc. (CRIS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Apollomics, Inc.|Narx-foyda koeffitsiyenti THAR|Narx-foyda multiplikatori ADVB (Advanced Biomed)|Narx-foyda koeffitsiyenti GNPX (Genprex, Inc)|CLDI: Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati sunshinebiopharma.com SBFM|XBIO - Narx-foyda koeffitsiyenti|SLRX: Narx-foyda koeffitsiyenti|Purple Biotech - Bozor narxining sof foydaga nisbati|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV